Skip to search formSkip to main contentSkip to account menu

raltegravir potassium

Known as: N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[ (5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide Monopotassium Salt, Potassium, Raltegravir, Raltegravir Potassium [Chemical/Ingredient] 
The orally bioavailable potassium salt of a human immunodeficiency virus (HIV) integrase strand transfer inhibitor (HIV-1 INSTI) with HIV-1 antiviral… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Ultra violet spectrophotometric estimation of the raltegravir potassium, an integrase inhibitor antiretroviral agent was… 
2013
2013
A simple, rapid, precise, and economical spectrophotometric method has been developed for quantitative analysis of Raltegravir… 
2011
2011
A high performance liquid chromatography and high performance thin layer liquid chromatography method were developed and… 
2011
2011
A High Performance Liquid Chromatographic (method A) and Ultra Violet spectrophotometric (method B) method were developed and… 
2011
2011
A High Performance Liquid Chromatographic (method A) and Ultra Violet spectrophotometric (method B) method were developed and… 
2010
2010
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2010
2010
  • Antimicrobial Agents and Chemotherapy
  • 2010
  • Corpus ID: 206702879
12 Apr 2007 Altabax (topical ointment) Retapamulin Glaxo Group For topical treatment of impetigo due to Staphylococcus aureus… 
2009
2009
Process for preparing raltegravir potassium in amorphous form comprising: a. raltegravir potassium stirring in water; b. removing… 
2008
2008
The UN and WHO currently estimate that 40 million people are living with HIV/AIDS worldwide. Combination therapies using reverse…